Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Divestments (2018 - 2019)

Historic Divestments for Ironwood Pharmaceuticals (IRWD) over the last 5 years, with Q1 2019 value amounting to -$4.2 million.

  • Ironwood Pharmaceuticals' Divestments changed N/A to -$4.2 million in Q1 2019 from the same period last year, while for Dec 2019 it was -$4.2 million, marking a year-over-year decrease of 12259.38%. This contributed to the annual value of -$4.2 million for FY2019, which is 4893.59% up from last year.
  • According to the latest figures from Q1 2019, Ironwood Pharmaceuticals' Divestments is -$4.2 million.
  • Ironwood Pharmaceuticals' 5-year Divestments high stood at -$3.0 million for Q4 2018, and its period low was -$4.2 million during Q1 2019.